What is the next
innovative therapy?



What is the next innovative drug modality?


SHIFTBIO has reached one step closer to holistic therapeutics using nanovesicles. Focus on the “next-generation paradigm shift” that nanovesicles and SHIFTBIO will lead.  

Exosome Platform Technology of SHIFTBIO 


- Maxisome, maximizing the therapeutic protein on the nanovesicle surface 

- InProDel, automatic protein loading into nanovesicle 

- Fusosome, membrane editing & intracellular delivery through membrane fusion

Our Pipeline

SHIFTBIO has new drug pipelines for rare and incurable diseases with high unmet medical needs. 

SIRP-NV 


Apelin-NV 


NV-HIF1α 


RSVF-NV 



SHIFTBIO aims to give a second chance to patients by developing innovative therapeutics. 


SEND